Merck's potential antiviral, molnupiravir, may generate $5 billion to $7 billion in sales through next year, company executives told analysts Thursday morning.
from Section Page News - Modern Healthcare https://ift.tt/3ErIJY9
Merck's potential antiviral, molnupiravir, may generate $5 billion to $7 billion in sales through next year, company executives told analysts Thursday morning.
No comments:
Post a Comment